Clinical and Cognitive Improvement Following Treatment with a Hemp-Derived, Full-Spectrum, High-Cannabidiol Product in Patients with Anxiety: An Open-Label Pilot Study

<b>Background/Objectives</b>: Cannabidiol (CBD) is a non-intoxicating cannabinoid touted for a variety of medical benefits, including alleviation of anxiety. While legalization of hemp-derived products in the United States (containing ≤0.3% delta-9-tetrahydrocannabinol [d9-THC] by weight...

Full description

Bibliographic Details

Published in:	Biomedicines
Main Authors:	Rosemary T. Smith, Mary Kathryn Dahlgren, Kelly A. Sagar, Deniz Kosereisoglu, Staci A. Gruber
Format:	Article
Language:	English
Published:	MDPI AG 2025-08-01
Subjects:	anxiety cannabidiol hemp cannabis
Online Access:	https://www.mdpi.com/2227-9059/13/8/1874